Cargando…

895. Impact of Measurement and Results Feedback of Chlorhexidine Gluconate (CHG) Skin Concentrations in Medical Intensive Care Unit (MICU) Patients Receiving CHG Bathing

BACKGROUND: Higher CHG skin levels may be needed to adequately control infection and transmission of pathogens in the ICU. We assessed whether measurement and feedback of patient CHG skin concentrations could improve CHG bathing quality and identified factors associated with higher CHG skin concentr...

Descripción completa

Detalles Bibliográficos
Autores principales: Rhee, Yoona, Hayden, Mary K, Simms, Andrew T, Yelin, Rachel D, Lolans, Karen, Bell, Pamela B, Schoeny, Michael, Baker, Arthur W, Baker, Meghan A, Gohil, Shruti K, Rhee, Chanu, Talati, Naasha, Warren, David K, Welbel, Sharon F, Dangana, Thelma E, Majalca, Thelma, Bravo, Heilen, Cass, Candice, Nelson, Alicia, Tolomeo, Pam C, Wolf, Robert, Lin, Michael Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809081/
http://dx.doi.org/10.1093/ofid/ofz359.054
_version_ 1783461897026142208
author Rhee, Yoona
Hayden, Mary K
Simms, Andrew T
Yelin, Rachel D
Lolans, Karen
Bell, Pamela B
Schoeny, Michael
Baker, Arthur W
Baker, Meghan A
Gohil, Shruti K
Rhee, Chanu
Talati, Naasha
Warren, David K
Welbel, Sharon F
Dangana, Thelma E
Majalca, Thelma
Bravo, Heilen
Cass, Candice
Nelson, Alicia
Tolomeo, Pam C
Wolf, Robert
Lin, Michael Y
author_facet Rhee, Yoona
Hayden, Mary K
Simms, Andrew T
Yelin, Rachel D
Lolans, Karen
Bell, Pamela B
Schoeny, Michael
Baker, Arthur W
Baker, Meghan A
Gohil, Shruti K
Rhee, Chanu
Talati, Naasha
Warren, David K
Welbel, Sharon F
Dangana, Thelma E
Majalca, Thelma
Bravo, Heilen
Cass, Candice
Nelson, Alicia
Tolomeo, Pam C
Wolf, Robert
Lin, Michael Y
author_sort Rhee, Yoona
collection PubMed
description BACKGROUND: Higher CHG skin levels may be needed to adequately control infection and transmission of pathogens in the ICU. We assessed whether measurement and feedback of patient CHG skin concentrations could improve CHG bathing quality and identified factors associated with higher CHG skin concentrations. METHODS: We conducted 6 one-day surveys from January 2018 to February 2019 in 7 academic hospital MICUs with established daily CHG bathing. Adults admitted >1 day were assessed for CHG skin levels with a semi-quantitative colorimetric assay using swabbed 25 cm(2) areas of anterior neck, axilla, and inguinal skin. Prior to survey 4, results from the first 3 surveys (baseline) were reported to ICU leadership and front-line staff to retrain and reeducate on bathing technique. Feedback of results from prior surveys also occurred before surveys 5 and 6. For statistical analysis, mixed-effects models accounted for clustering of CHG measurements within patients and ICUs. We categorized CHG product type as “cloth” for no-rinse 2% CHG-impregnated cloth and “liquid” for 4% CHG liquid or foam. RESULTS: In total, 681 of 704 (97%) patients were enrolled. Three ICUs used CHG cloth, 3 ICUs used CHG liquid, and 1 ICU switched from liquid to cloth after the second survey. Median CHG skin concentrations were higher in both the baseline and feedback period for institutions using CHG cloth, as compared with liquid (table). Across all time points, axillary and inguinal regions had higher skin CHG concentrations than the neck (median 39.1, 78.1, 19.5 µg/mL, respectively, P < 0.001). After controlling for age, mechanical ventilation, presence of a central venous catheter, body site, and hours since last CHG bath, institutions that used CHG cloth had a 3-fold increase in adjusted CHG skin concentrations in the feedback period compared with the baseline period (P = 0.001, Figure). There was no significant change in CHG skin concentrations from baseline to feedback period for institutions that used liquid CHG. CONCLUSION: CHG skin concentrations on MICU patients receiving daily CHG bathing varied by body site and CHG product type. The use of CHG cloth was associated with higher CHG skin levels, compared with CHG liquid. For ICUs using CHG cloth, feedback of CHG skin concentration results to ICU staff improved CHG bathing quality. [Image: see text] [Image: see text] DISCLOSURES: All Authors: No reported Disclosures.
format Online
Article
Text
id pubmed-6809081
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68090812019-10-28 895. Impact of Measurement and Results Feedback of Chlorhexidine Gluconate (CHG) Skin Concentrations in Medical Intensive Care Unit (MICU) Patients Receiving CHG Bathing Rhee, Yoona Hayden, Mary K Simms, Andrew T Yelin, Rachel D Lolans, Karen Bell, Pamela B Schoeny, Michael Baker, Arthur W Baker, Meghan A Gohil, Shruti K Rhee, Chanu Talati, Naasha Warren, David K Welbel, Sharon F Dangana, Thelma E Majalca, Thelma Bravo, Heilen Cass, Candice Nelson, Alicia Tolomeo, Pam C Wolf, Robert Lin, Michael Y Open Forum Infect Dis Abstracts BACKGROUND: Higher CHG skin levels may be needed to adequately control infection and transmission of pathogens in the ICU. We assessed whether measurement and feedback of patient CHG skin concentrations could improve CHG bathing quality and identified factors associated with higher CHG skin concentrations. METHODS: We conducted 6 one-day surveys from January 2018 to February 2019 in 7 academic hospital MICUs with established daily CHG bathing. Adults admitted >1 day were assessed for CHG skin levels with a semi-quantitative colorimetric assay using swabbed 25 cm(2) areas of anterior neck, axilla, and inguinal skin. Prior to survey 4, results from the first 3 surveys (baseline) were reported to ICU leadership and front-line staff to retrain and reeducate on bathing technique. Feedback of results from prior surveys also occurred before surveys 5 and 6. For statistical analysis, mixed-effects models accounted for clustering of CHG measurements within patients and ICUs. We categorized CHG product type as “cloth” for no-rinse 2% CHG-impregnated cloth and “liquid” for 4% CHG liquid or foam. RESULTS: In total, 681 of 704 (97%) patients were enrolled. Three ICUs used CHG cloth, 3 ICUs used CHG liquid, and 1 ICU switched from liquid to cloth after the second survey. Median CHG skin concentrations were higher in both the baseline and feedback period for institutions using CHG cloth, as compared with liquid (table). Across all time points, axillary and inguinal regions had higher skin CHG concentrations than the neck (median 39.1, 78.1, 19.5 µg/mL, respectively, P < 0.001). After controlling for age, mechanical ventilation, presence of a central venous catheter, body site, and hours since last CHG bath, institutions that used CHG cloth had a 3-fold increase in adjusted CHG skin concentrations in the feedback period compared with the baseline period (P = 0.001, Figure). There was no significant change in CHG skin concentrations from baseline to feedback period for institutions that used liquid CHG. CONCLUSION: CHG skin concentrations on MICU patients receiving daily CHG bathing varied by body site and CHG product type. The use of CHG cloth was associated with higher CHG skin levels, compared with CHG liquid. For ICUs using CHG cloth, feedback of CHG skin concentration results to ICU staff improved CHG bathing quality. [Image: see text] [Image: see text] DISCLOSURES: All Authors: No reported Disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6809081/ http://dx.doi.org/10.1093/ofid/ofz359.054 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Rhee, Yoona
Hayden, Mary K
Simms, Andrew T
Yelin, Rachel D
Lolans, Karen
Bell, Pamela B
Schoeny, Michael
Baker, Arthur W
Baker, Meghan A
Gohil, Shruti K
Rhee, Chanu
Talati, Naasha
Warren, David K
Welbel, Sharon F
Dangana, Thelma E
Majalca, Thelma
Bravo, Heilen
Cass, Candice
Nelson, Alicia
Tolomeo, Pam C
Wolf, Robert
Lin, Michael Y
895. Impact of Measurement and Results Feedback of Chlorhexidine Gluconate (CHG) Skin Concentrations in Medical Intensive Care Unit (MICU) Patients Receiving CHG Bathing
title 895. Impact of Measurement and Results Feedback of Chlorhexidine Gluconate (CHG) Skin Concentrations in Medical Intensive Care Unit (MICU) Patients Receiving CHG Bathing
title_full 895. Impact of Measurement and Results Feedback of Chlorhexidine Gluconate (CHG) Skin Concentrations in Medical Intensive Care Unit (MICU) Patients Receiving CHG Bathing
title_fullStr 895. Impact of Measurement and Results Feedback of Chlorhexidine Gluconate (CHG) Skin Concentrations in Medical Intensive Care Unit (MICU) Patients Receiving CHG Bathing
title_full_unstemmed 895. Impact of Measurement and Results Feedback of Chlorhexidine Gluconate (CHG) Skin Concentrations in Medical Intensive Care Unit (MICU) Patients Receiving CHG Bathing
title_short 895. Impact of Measurement and Results Feedback of Chlorhexidine Gluconate (CHG) Skin Concentrations in Medical Intensive Care Unit (MICU) Patients Receiving CHG Bathing
title_sort 895. impact of measurement and results feedback of chlorhexidine gluconate (chg) skin concentrations in medical intensive care unit (micu) patients receiving chg bathing
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809081/
http://dx.doi.org/10.1093/ofid/ofz359.054
work_keys_str_mv AT rheeyoona 895impactofmeasurementandresultsfeedbackofchlorhexidinegluconatechgskinconcentrationsinmedicalintensivecareunitmicupatientsreceivingchgbathing
AT haydenmaryk 895impactofmeasurementandresultsfeedbackofchlorhexidinegluconatechgskinconcentrationsinmedicalintensivecareunitmicupatientsreceivingchgbathing
AT simmsandrewt 895impactofmeasurementandresultsfeedbackofchlorhexidinegluconatechgskinconcentrationsinmedicalintensivecareunitmicupatientsreceivingchgbathing
AT yelinracheld 895impactofmeasurementandresultsfeedbackofchlorhexidinegluconatechgskinconcentrationsinmedicalintensivecareunitmicupatientsreceivingchgbathing
AT lolanskaren 895impactofmeasurementandresultsfeedbackofchlorhexidinegluconatechgskinconcentrationsinmedicalintensivecareunitmicupatientsreceivingchgbathing
AT bellpamelab 895impactofmeasurementandresultsfeedbackofchlorhexidinegluconatechgskinconcentrationsinmedicalintensivecareunitmicupatientsreceivingchgbathing
AT schoenymichael 895impactofmeasurementandresultsfeedbackofchlorhexidinegluconatechgskinconcentrationsinmedicalintensivecareunitmicupatientsreceivingchgbathing
AT bakerarthurw 895impactofmeasurementandresultsfeedbackofchlorhexidinegluconatechgskinconcentrationsinmedicalintensivecareunitmicupatientsreceivingchgbathing
AT bakermeghana 895impactofmeasurementandresultsfeedbackofchlorhexidinegluconatechgskinconcentrationsinmedicalintensivecareunitmicupatientsreceivingchgbathing
AT gohilshrutik 895impactofmeasurementandresultsfeedbackofchlorhexidinegluconatechgskinconcentrationsinmedicalintensivecareunitmicupatientsreceivingchgbathing
AT rheechanu 895impactofmeasurementandresultsfeedbackofchlorhexidinegluconatechgskinconcentrationsinmedicalintensivecareunitmicupatientsreceivingchgbathing
AT talatinaasha 895impactofmeasurementandresultsfeedbackofchlorhexidinegluconatechgskinconcentrationsinmedicalintensivecareunitmicupatientsreceivingchgbathing
AT warrendavidk 895impactofmeasurementandresultsfeedbackofchlorhexidinegluconatechgskinconcentrationsinmedicalintensivecareunitmicupatientsreceivingchgbathing
AT welbelsharonf 895impactofmeasurementandresultsfeedbackofchlorhexidinegluconatechgskinconcentrationsinmedicalintensivecareunitmicupatientsreceivingchgbathing
AT danganathelmae 895impactofmeasurementandresultsfeedbackofchlorhexidinegluconatechgskinconcentrationsinmedicalintensivecareunitmicupatientsreceivingchgbathing
AT majalcathelma 895impactofmeasurementandresultsfeedbackofchlorhexidinegluconatechgskinconcentrationsinmedicalintensivecareunitmicupatientsreceivingchgbathing
AT bravoheilen 895impactofmeasurementandresultsfeedbackofchlorhexidinegluconatechgskinconcentrationsinmedicalintensivecareunitmicupatientsreceivingchgbathing
AT casscandice 895impactofmeasurementandresultsfeedbackofchlorhexidinegluconatechgskinconcentrationsinmedicalintensivecareunitmicupatientsreceivingchgbathing
AT nelsonalicia 895impactofmeasurementandresultsfeedbackofchlorhexidinegluconatechgskinconcentrationsinmedicalintensivecareunitmicupatientsreceivingchgbathing
AT tolomeopamc 895impactofmeasurementandresultsfeedbackofchlorhexidinegluconatechgskinconcentrationsinmedicalintensivecareunitmicupatientsreceivingchgbathing
AT wolfrobert 895impactofmeasurementandresultsfeedbackofchlorhexidinegluconatechgskinconcentrationsinmedicalintensivecareunitmicupatientsreceivingchgbathing
AT linmichaely 895impactofmeasurementandresultsfeedbackofchlorhexidinegluconatechgskinconcentrationsinmedicalintensivecareunitmicupatientsreceivingchgbathing